ICASA 2023 – 22nd International Conference on AIDS and STIs in Africa (ICASA)
4 – 9 December in Harare, Zimbabwe
ICASA 2023 provides an opportunity to highlight the challenges and successes of the HIV, hepatitis and STI responses across the WHO’s African Region, while addressing HIV/STI research, and implementation science in the context of wider pandemic preparedness and response. WHO is convening 8 main satellites sessions and 2 special sessions, to share its latest scientific and normative work on the following areas:
- Differentiated Service Delivery;
- Key populations and stigma;
- New WHO guidelines on HIV, viral hepatitis and STIs;
- PrEP and long-acting products;
- TB prevention;
- Outbreaks and emergencies, preparedness;
- HIV and non-communicable diseases integration;
- Elimination of mother-to-child transmission (MTCT);
- Special sessions (with SAA ICASA);
- Vaccines (Malaria); and
- Hepatitis.
Furthermore, WHO will have a leading role across the conference agenda and pre-meetings, including the participation in the opening ceremony, plenary sessions, press conferences, workshops, bilateral meetings and engaging with communities and people living with or affected by HIV.
About ICASA
The biennial International Conference on AIDS and STIs in Africa, ICASA, is the main and largest African forum for bringing together key HIV, sexually transmitted infections (STI) and communicable disease stakeholders, including heads of state and government, ministers, national HIV programmes staff, advocates, scientists, policymakers, service providers, donors, civil society representatives, communities and people living with HIV and STIs.
The ICASA Conference is Africa’s most influential meeting on HIV/STIs. It is organised by the Society for AIDS in Africa which was founded in 1989. WHO is a standing co-organizer of ICASA and takes this opportunity every 2 years to promote and present its policies, guidelines and tools, and to demonstrate its leadership and contribution to the health sector responses to HIV, STIs, hepatitis, monkeypox, and integrated approaches for service delivery. The ICASA Conference attracts up to 4 000 participants from most WHO Member States in Africa; therefore, it is an event of prime importance in the context of HIV, hepatitis and STIs.
